Differential expression of caveolin-1 in renal neoplasms

Cancer

Volumn 110, Issue 4, 2007, Pages 776-782

  Tamaskar, Ila ^a   Choueiri, Toni K ^a   Sercia, Linda ^b   Rini, Brian ^a   Bukowski, Ronald ^a   Zhou, Ming ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Caveolin 1; Immunohistochemistry; Renal cell carcinoma; Renal neoplasms; Tissue microarray

Indexed keywords

CAVEOLIN 1;

ADULT; AGED; ARTICLE; BOWMAN CAPSULE; CANCER GRADING; CANCER STAGING; CELL ADHESION; CELL TRANSPORT; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; LIPID RAFT; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; TISSUE MICROARRAY; TUMOR VOLUME; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA, CLEAR CELL; ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CAVEOLIN 1; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TISSUE ARRAY ANALYSIS;

EID: 34547886475     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22838     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
2. Anderson RG. The caveolae membrane system. Annu Rev Biochem. 1998;67:199-225.
3. Bender FC. Reymond MA. Bron C, et al. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 2000;60:5870-5878.
4. Weichen K, Diatchenko L, Agoulnik A, et al. Caveolin-1 is downregulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol. 2001;159:1635-1643.
5. Racine C, Belanger M. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun. 1999;255:580-586.
6. Wiechen K, Sers C, Agoulnik A, et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol. 2001;158:833-839.
7. Ito Y, Yoshida H, Nakano K, et al. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer. 2002;86:912-916.
8. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK. Caveolin-1 expression is associated with high-grade bladder cancer. Urology. 2001;58:811-814.
9. Suzuoki M, Miyamoto M, Kato K, et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer. 2002;87:1140-1144.
10. Kato K, Hida Y, Miyamoto M, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002;94:929-933.
11. Carrion R, Morgan BE, Tannenbaum M, Salup R, Morgan MB. Caveolin expression in adult renal tumors. Urol Oncol. 2003;21:191-196.
12. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch. 2005;447:938-946.
13. Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathol. 2006;125:392-398.
14. Campbell L, Gumbleton M, Griffiths DFR. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. Br J Cancer. 2003;89:1909-1913.
15. Horiguchi A, Asano T, Asakuma J, et al. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma. J Urol. 2004;172:718-722.
16. Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int. 2004;93:291-296.
17. Medeiros LJ, Jones EC, Aizawa SA, et al. Grading of renal cell carcinoma: Workgroup No. 2. Cancer. 1997;80:990-991.
18. Guinan P, Sobin LH, Algaba F, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) andthe American Joint Committee on Cancer (AJCC). Cancer. 1997;80:992-993.
19. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev. 2004;84:1341-1379.
20. Liu J, Razani B, Tang S, Terman BI, Ware AJ, Lisanti MP. Angiogenesis activators and inhibitors differently regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. J Biol Chem. 1999;274:15781-15785.
21. Okamoto T, Schlegel A, Scherer P, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes: and the plasma membrane. J Biol Chem. 1998;273:5419-5422.
22. Breton S, Lisanti MP, Tyszkowski R, et al. Basolateral distribution of caveolin-1 in the kidney: absence from H+-ATPase-coated endocytic vesicles. J Histochem Cytochem. 1998;46:205-214.
23. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem. 2002;277:41295-41298.
24. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005;288:C494-C506.
25. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 1999;59:5719-5723.
26. Li L, Yang G, Ebara S, et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 2001;61:4386-4392.
27. Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol. 2002;161:1647-1656.
28. Davidson B, Nesland JM, Goldberg I, et al. Caveolin-1 expression in advanced-stage ovarian carcinoma - a clinicopathologic study. Gynecol Oncol. 2001;81:166-171.
29. Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene. 2004;23:7893-7897.
30. Hurlstone AF, Reid G, Reeves JR, et al. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene. 1999;18:1881-1890.
31. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-291.
32. Takehara K, Sakai H, Koga S, Kanetake H. Immunohistochemical expression of caveolin-1 as a marker for the biological potential of renal cell carcinoma. [abstract]. J Urol. 2002;167(suppl):132.
33. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer-Verlag; 2002:323-328.
34. Richardson PG, Barlogie B, Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003;348:2609-2617.
35. Kondagunta GV, Drucker B, Schwartz L, et al. Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol. 2004;22:3720-3725.